Kewaunee Scientific Co. (NASDAQ:KEQU) CFO Donald T. Gardner III Sells 3,000 Shares

Kewaunee Scientific Co. (NASDAQ:KEQU - Get Free Report) CFO Donald T. Gardner III sold 3,000 shares of the business's stock in a transaction that occurred on Wednesday, April 9th. The stock was sold at an average price of $37.75, for a total value of $113,250.00. Following the sale, the chief financial officer now owns 15,358 shares of the company's stock, valued at $579,764.50. The trade was a 16.34 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Kewaunee Scientific Stock Up 1.1 %

KEQU traded up $0.39 during trading hours on Wednesday, hitting $34.48. 1,851 shares of the company's stock were exchanged, compared to its average volume of 23,719. The company has a current ratio of 2.64, a quick ratio of 2.13 and a debt-to-equity ratio of 0.45. Kewaunee Scientific Co. has a 12-month low of $30.82 and a 12-month high of $71.33. The firm has a market cap of $98.44 million, a P/E ratio of 5.46 and a beta of 0.59. The firm has a 50 day moving average of $48.40 and a 200 day moving average of $47.35.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last issued its quarterly earnings results on Wednesday, March 12th. The technology company reported $1.09 earnings per share for the quarter. Kewaunee Scientific had a return on equity of 25.83% and a net margin of 9.39%. The company had revenue of $67.17 million for the quarter.

Institutional Investors Weigh In On Kewaunee Scientific

Hedge funds and other institutional investors have recently modified their holdings of the company. Bank of America Corp DE increased its holdings in Kewaunee Scientific by 2,605.9% in the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company's stock valued at $28,000 after buying an additional 443 shares during the last quarter. Jane Street Group LLC acquired a new stake in Kewaunee Scientific during the 4th quarter worth $300,000. Marshall Wace LLP purchased a new position in Kewaunee Scientific during the 4th quarter worth $736,000. Invesco Ltd. acquired a new position in Kewaunee Scientific in the fourth quarter valued at $6,545,000. Finally, Wedbush Securities Inc. purchased a new stake in shares of Kewaunee Scientific in the fourth quarter valued at about $262,000. 32.69% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, StockNews.com lowered Kewaunee Scientific from a "buy" rating to a "hold" rating in a research report on Friday, March 14th.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.